Loading clinical trials...

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma | Clinical Trials | Clareo Health

TERMINATEDPhase 2NCT01746173

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

The current standard of care for the frontline treatment of peripheral T-cell lymphomas (PTCL) is induction chemotherapy followed by autologous stem cell transplantation (ASCT). However, many patients...

Lead sponsor: Dana-Farber Cancer Institute•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

NCT07356245 · T-cell Lymphoma, Graft Versus Host Disease, and more

RECRUITINGPhase 1

Q702 for the Treatment of Patients With Hematologic Malignancies

NCT06712810 · Hematopoietic and Lymphatic System Neoplasm, Histiocytic Sarcoma, and more

RECRUITINGPhase 1/2

CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas

NCT07022964 · T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)

RECRUITINGPhase 1/2

CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas

NCT06925464 · T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)

RECRUITINGPhase 2

Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas

NCT02859402 · T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 30, 2023Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment5

Start dateJul 2013

Last updatedJan 30, 2023

Condition

T-cell Non-Hodgkin Lymphoma

Locations shown

Brigham and Women's Hospital

Boston, Massachusetts

Dana-Farber Cancer Institute

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 30, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions